Contact
searchSearch
HMP Global
Videos

What are the common psychosocial issues faced by our IBD patients?

08/08/2018

Latest News

News
FDA Expands Approval of Mirikizumab to Crohn's Disease 
01/16/2025
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved...
01/16/2025
Advances in Inflammatory Bowel Disease Network
News
Stem Cell Therapy Shows Promise for Medically Refractory Crohn’s Disease
12/16/2024
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem...
12/16/2024
Advances in Inflammatory Bowel Disease Network
News
Study Highlights Effectiveness of Medical Therapies for Fistulizing Crohn’s Disease
12/13/2024
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing...
12/13/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Effective for Crohn’s Disease Regardless of Prior Biologic Failure
12/06/2024
The Janus kinase inhibitor showed definite superiority over placebo in inducing and maintaining clinical remission and endoscopic response among patients who did not respond or lost response to biologic therapies for Crohn’s disease.
The Janus kinase inhibitor showed definite superiority over placebo in inducing and maintaining clinical remission and endoscopic response among patients who did not respond or lost response to biologic therapies for Crohn’s disease.
The Janus kinase inhibitor...
12/06/2024
Advances in Inflammatory Bowel Disease Network
News
MRI and Blood Biomarkers Predict Surgery Risk in Ileal Crohn’s Disease
12/05/2024
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Extraintestinal Risks in IBD: Who’s Most Vulnerable?
12/05/2024
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
A large cohort study reveals key...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Advanced Therapies for Patients With Severe Ulcerative Colitis
12/05/2024
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
AI Breakthrough in Crohn’s Disease: Automated Imaging Enhances Diagnosis
12/04/2024
A new deep learning model accurately identifies Crohn’s disease lesions and assesses disease activity, offering radiologists a powerful tool for precision care.
A new deep learning model accurately identifies Crohn’s disease lesions and assesses disease activity, offering radiologists a powerful tool for precision care.
A new deep learning model...
12/04/2024
Advances in Inflammatory Bowel Disease Network
News
Intestinal Ultrasound Predicts Response to Therapy in Ulcerative Colitis
11/26/2024
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as...
11/26/2024
Advances in Inflammatory Bowel Disease Network

Latest Podcasts

IBD Drive time logo
Podcast
IBD Drive Time: Lin Chang, MD, on IBS in IBD
01/27/2025
Dr Lin Chang joins hosts Raymond Cross, MD, and Millie Long, MD, to discuss how patient with inflammatory bowel disease may also have underlying irritable bowel syndrome, how to diagnose the condition, and the best options for treatment.
Dr Lin Chang joins hosts Raymond Cross, MD, and Millie Long, MD, to discuss how patient with inflammatory bowel disease may also have underlying irritable bowel syndrome, how to diagnose the condition, and the best options for treatment.
Dr Lin Chang joins hosts Raymond...
01/27/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use